De Guia, Juliet A.

HRN: 11-08-61  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/11/2023
CEFTRIAXONE 1G (VIAL)
01/11/2023
01/17/2023
IVT
2gms
Od
Cap Mr, Ptb Presumptive
Waiting Final Action 
01/11/2023
AZITHROMYCIN 500MG TABLET (TAB)
01/11/2023
01/15/2023
PO
500mg
Od
Cap Mr, Presumptive Ptb
Waiting Final Action 
01/16/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/15/2023
01/22/2023
IV
1.5 G
Q6H
T/c Lung Abscess, CAP-MR
Waiting Final Action 
01/16/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/15/2023
01/22/2023
IV
600 Mg
Q6H
T/c Lung Abscess, CAP-MR
Waiting Final Action 
01/17/2023
LEVOFLOXACIN 500MG (TAB)
01/17/2023
01/23/2023
ORAL
750 Mg
Q24H
Community Acquired Pneumonia - Moderate Risk
Waiting Final Action 
01/17/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/17/2023
01/23/2023
IV
4.5g
Q8H
Community Acquired Pneumonia - Moderate Risk
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: